Mats Heyman
Clinical trials sponsored by Mats Heyman, explained in plain language.
-
Massive new trial aims to beat childhood leukemia with smarter, safer treatment
Disease control Recruiting nowThis study is testing a new treatment plan for children and young adults (up to age 45) newly diagnosed with acute lymphoblastic leukemia (ALL). It combines successful approaches from previous studies to improve survival and reduce side effects. About 6,430 participants will be e…
Phase: PHASE3 • Sponsor: Mats Heyman • Aim: Disease control
Last updated May 08, 2026 12:01 UTC
-
Leukemia study prepares ground for future breakthroughs
Knowledge-focused Recruiting nowThis pilot study is getting ready for a larger trial by checking how well hospitals can collect data and give standard treatments to children and young adults (up to age 45) with newly diagnosed acute lymphoblastic leukemia. About 500 participants will receive usual care, and res…
Sponsor: Mats Heyman • Aim: Knowledge-focused
Last updated May 26, 2026 11:59 UTC